Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing"

The New England Journal of Medicine
J Avorn, S B Soumerai

Abstract

Improving precision and economy in the prescribing of drugs is a goal whose importance has increased with the proliferation of new and potent agents and with growing economic pressures to contain health-care costs. We implemented an office-based physician education program to reduce the excessive use of three drug groups: cerebral and peripheral vasodilators, an oral cephalosporin, and propoxyphene. A four-state sample of 435 prescribers of these drugs was identified through Medicaid records and randomly assigned to one of three groups. Physicians who were offered personal educational visits by clinical pharmacists along with a series of mailed "unadvertisements" reduced their prescribing of the target drugs by 14 per cent as compared with controls (P = 0.0001). A comparable reduction in the number of dollars reimbursed for these drugs was also seen between the two groups, resulting in substantial cost savings. No such change was seen in physicians who received mailed print materials only. The effect persisted for at least nine months after the start of the intervention, and no significant increase in the use of expensive substitute drugs was found. Academically based "detailing" may represent a useful and cost-effective way to...Continue Reading

References

Mar 29, 1979·The New England Journal of Medicine·J D Coffman
Feb 1, 1979·Archives of General Psychiatry·J A YesavageP A Berger
Dec 9, 1976·The New England Journal of Medicine·C J McDonald
Jul 31, 1975·The New England Journal of Medicine·H H Hiatt
Apr 13, 1972·The New England Journal of Medicine·C G MoertelN Schwartau
Sep 4, 1972·JAMA : the Journal of the American Medical Association·F S Tennant
Oct 1, 1973·Annals of Internal Medicine·C M KuninW A Craig
Jan 29, 1970·The New England Journal of Medicine·C E Lewis, R S Hassanein
Jan 1, 1967·Journal of Personality and Social Psychology·W A Watts
Jul 30, 1981·The New England Journal of Medicine·H L Smits
Jul 1, 1982·The American Journal of Medicine·J AvornR Hartley
Nov 13, 1981·JAMA : the Journal of the American Medical Association·J M Eisenberg, S V Williams
Dec 11, 1981·Science·T H Maugh
Sep 1, 1980·Psychological Bulletin·Howard Leventhal, Paul D Cleary

❮ Previous
Next ❯

Citations

Aug 15, 2001·Pharmacoepidemiology and Drug Safety·W Smalley
Aug 19, 1988·Pharmaceutisch Weekblad. Scientific Edition·T D Rucker
Mar 1, 1987·Journal of General Internal Medicine·A FarynaK Goldenberg
May 1, 1994·Australian Family Physician·N Abraham
Sep 1, 1990·Journal of General Internal Medicine·R S Lawrence
Nov 1, 1990·Journal of General Internal Medicine·F A Lederle, E M Rogers
Jul 4, 2006·Indian Journal of Pediatrics·Aditya H Gaur, B Keith English
Jan 13, 2006·European Journal of Clinical Pharmacology·Lisa K Pulver, Susan E Tett
Feb 3, 2007·Pharmacy World & Science : PWS·Vera von GuntenJohnny Beney
Apr 28, 2007·Pharmacy World & Science : PWS·Fernando Fernandez-Llimos, Isabel Vazquez Gomez
Mar 16, 2007·Journal of General Internal Medicine·Daniel H SolomonM Alan Brookhart
Jul 16, 2008·Journal of General Internal Medicine·Robert S WigtonRalph Gonzales
Nov 15, 1992·Biological Psychiatry·J Wortis, A Stone
Nov 6, 1993·Lancet·H G Leufkens, J Urquhart
May 1, 1995·Clinical Therapeutics·G J Okano, K L Rascati
Dec 12, 1983·Evaluation and Program Planning·M S Thompson, C P King
Nov 4, 1995·Health Policy·D E KanouseJ P Kahan
Jan 1, 1988·Social Science & Medicine·P DenigD H Zijsling
Jan 1, 1989·Social Science & Medicine·R K SchwartzJ Avorn
Jan 1, 1990·Social Science & Medicine·G J WalkerF A Kassem
Jan 1, 1991·Social Science & Medicine·M U Adikwu, B O Osondu
Apr 1, 1996·Social Science & Medicine·P GoelS Soumerai
Mar 1, 1996·Journal of Pain and Symptom Management·R McQuillanM Spencer
Mar 1, 1996·Journal of Clinical Epidemiology·A BexellV K Diwan
Sep 1, 1995·Journal of Clinical Anesthesia·R E JohnstoneD Sullivan
Feb 19, 2004·The American Journal of Medicine·Stephan D FihnArthur Sauvigne
Apr 20, 2005·Contemporary Clinical Trials·Daniel H SolomonJerry Avorn
Nov 1, 2003·Current Therapeutic Research, Clinical and Experimental·Mickie PreisHaim Reuveni
Jan 22, 1998·Journal of Pain and Symptom Management·M L LevinJ Leiter
Sep 10, 1998·Journal of Clinical Epidemiology·V ThamlikitkulS Ckokloikaew
Jan 1, 1993·International Journal of Technology Assessment in Health Care·J Lomas
Jan 1, 1995·International Journal of Technology Assessment in Health Care·H L LiptonE A Chrischilles
Aug 9, 2008·Nature Biotechnology·Mark Ratner, Trisha Gura
May 13, 1998·British Journal of Clinical Pharmacology·J C Mucklow
Mar 7, 2002·Journal of Advanced Nursing·Gill HarveyKate Seers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.